About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Phoenix | 52 Studies

Clinical Trials COVID-19Phoenix

COVID-19 Clinical Trials in Phoenix

Find 52 clinical trials for covid-19 near Phoenix, Arizona. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 52 trials

CompletedA Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-1283.222 versus mRNA-1273.222…NCT05815498·Huntsville, Alabama and 229 others

COVID-19 Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedA Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.NCT04421508·Phoenix, Arizona and 16 others

TerminatedStudy to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)The purpose of the study is to determine if Liquid Alpha1-Proteinase Inhibitor (Human) (Liquid Alpha1-PI) plus SMT can reduce the proportion of participants dying or requiring…NCT04547140·Birmingham, Alabama and 19 others

UnknownPhase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19The primary objective of this study is to assess whether the use of lenzilumab in addition to current standard of care can alleviate the immune-mediated cytokine release syndrome…NCT04351152·Phoenix, Arizona and 28 others

CompletedTo Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.Substudy A: The study will evaluate the safety, tolerability, and efficacy of a booster dose of BNT162b2 when administered to participants having previously received 2 doses of…NCT04955626·Athens, Alabama and 153 others

TerminatedStudy of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19The purpose of this study is to assess the safety and efficacy of merimepodib (MMPD) oral solution when administered in combination with remdesivir in adult patients with advanced…NCT04410354·Phoenix, Arizona and 9 others

TerminatedJanssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant RecipientsThe purpose of this research is to see if a dose of the Janssen Ad26.CoV2.S vaccine effects the immune protection in individuals who have had a kidney transplant and two or three…NCT05220397·Phoenix, Arizona and 2 others

CompletedEfficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of ConcernThe study will evaluate the clinical efficacy of different dosing regimens of the Moderna COVID-19 mRNA vaccine (100 mcg) in preventing COVID-19 disease in people who are living…NCT05168813·Gaborone and 46 others

CompletedStudy to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsThis is a Phase 1/2/3, randomized, placebo-controlled, observer-blind, dose-finding, vaccine candidate-selection, and efficacy study in healthy individuals.NCT04368728·Athens, Alabama and 174 others

CompletedThe Prevent Severe COVID-19 (PRESECO) StudyDouble-blinded, placebo control, randomized, phase-3 clinical trial to evaluate clinical efficacy of Favipiravir in patients with mild to moderate symptoms related to COVID-19…NCT04600895·Pelham, Alabama and 37 others

CompletedTo Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and OlderResults will be submitted, however please note that data are not yet available for all serology outcome measures.NCT04754594·Birmingham, Alabama and 89 others

CompletedRECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID SymptomsThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be…NCT05595369·Birmingham, Alabama and 68 others

TerminatedA Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With OfatumumabThis study evaluated if relapsing multiple sclerosis (MS) participants treated with ofatumumab 20 mg subcutaneous (s.c.) administered once monthly could develop an adequate immune…NCT04878211·Phoenix, Arizona and 6 others

CompletedRECOVER-AUTONOMIC Platform ProtocolThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be…NCT06305780·Opelika, Alabama and 49 others

Active not recruitingA Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 InfectionThe primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet…NCT06672055·Anniston, Alabama and 144 others

UnknownDapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19This is a multi-center, randomized, triple-blind, placebo-controlled (RCT) study to evaluate the efficacy and safety of Dapsone in older adults, and/or in adult patients (≥40yrs…NCT04935476·Phoenix, Arizona and 6 others

TerminatedSilmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)This multi-center, open-label, 2 arm parallel-group, randomized, interventional prospective exploratory study in 40 patients aimed to evaluate safety and explore putative clinical…NCT04668209·Phoenix, Arizona and 1 other

TerminatedSafety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 ExposureThis is a Phase 2/3, randomized, placebo-controlled, multi-center trial to evaluate the safety, immunogenicity and efficacy of INO-4800 administered by intradermal (ID) injection…NCT04642638·Chandler, Arizona and 26 others

CompletedA Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of AgeThe primary goal for this study is to evaluate up to 3 dose levels of mRNA-1273 vaccine given to healthy children as intramuscular (IM) injection in 2 doses (in Parts 1 and 2) and…NCT04796896·Birmingham, Alabama and 90 others

CompletedA Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 VaccineThe purpose of this study is to assess SARS CoV-2 infection, viral shedding, and subsequent potential transmission in individuals immunized with the Moderna COVID-19 vaccine.NCT04811664·Birmingham, Alabama and 50 others

PreviousPage 2 of 3Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia